Cargando…

P1180: BURKITT INTERNATIONAL PROGNOSTIC INDEX EVALUATED IN PATIENTS TREATED WITH R-GMALL PROTOCOL

Detalles Bibliográficos
Autores principales:	Rizzuto, Giuliana, Mazzon, Federico, Pavoni, Chiara, Maria Barbui, Anna, Ferrari, Silvia, Gritti, Giuseppe, Grassi, Anna, Lussana, Federico, Intermesoli, Tamara, Rambaldi, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430903/ http://dx.doi.org/10.1097/01.HS9.0000971616.39998.b5

Ejemplares similares

Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with NPM1 Positive Acute Myeloid Leukemia
por: Lussana, Federico, et al.
Publicado: (2019)

Immunotherapy of Acute Lymphoblastic Leukemia and Lymphoma With T Cell–Redirected Bispecific Antibodies
por: Lussana, Federico, et al.
Publicado: (2021)

MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL
por: Tosi, Manuela, et al.
Publicado: (2021)

Is There a Role for Minimal Residual Disease Monitoring in Follicular Lymphoma in the Chemo-Immunotherapy Era?
por: Gritti, Giuseppe, et al.
Publicado: (2017)

Role of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia
por: Lussana, Federico, et al.
Publicado: (2014)

Concurrent Diagnosis of Acute Myeloid Leukemia and Symptomatic COVID-19 Infection: a Case Report Successfully Treated with Azacitidine-Venetoclax Combination
por: Taurino, Daniela, et al.
Publicado: (2021)

Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy
por: Gritti, Giuseppe, et al.
Publicado: (2018)

Optimal Use of Novel Immunotherapeutics in B-Cell Precursor ALL
por: Lussana, Federico, et al.
Publicado: (2023)

Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera
por: Lussana, Federico, et al.
Publicado: (2017)

Capture-Based Next-Generation Sequencing Improves the Identification of Immunoglobulin/T-Cell Receptor Clonal Markers and Gene Mutations in Adult Acute Lymphoblastic Leukemia Patients Lacking Molecular Probes
por: Cavagna, Roberta, et al.
Publicado: (2020)

Primary Treatment Response Rather than Front Line Stem Cell Transplantation Is Crucial for Long Term Outcome of Peripheral T-Cell Lymphomas
por: Gritti, Giuseppe, et al.
Publicado: (2015)

Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1‐JAK2 positive myeloid sarcoma and acute B‐lymphoblastic leukemia
por: Rizzuto, Giuliana, et al.
Publicado: (2022)

Immature Immunoglobulin Gene Rearrangements Are Recurrent in B Precursor Adult Acute Lymphoblastic Leukemia Carrying TP53 Molecular Alterations
por: Salmoiraghi, Silvia, et al.
Publicado: (2020)

High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG)
por: Salmoiraghi, Silvia, et al.
Publicado: (2020)

Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06
por: Caprioli, Chiara, et al.
Publicado: (2020)

Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an “Old-fashioned” Drug be Effective?
por: Riva, Marta, et al.
Publicado: (2023)

1180. Empiric treatment of uncomplicated intraabdominal infection with cefazolin with or without metronidazole
por: Borkowski, Jaime, et al.
Publicado: (2023)

Chemical interaction between sea-salt and tellurium, between 300 and 1180 K
por: Espegren, Fredrik, et al.
Publicado: (2018)

PB2135: BURKITT LYMPHOMA INTERNATIONAL PROGNOSTIC INDEX (BL-IPI): IS IT EFFICIENT ENOUGH IN ADULT BURKITT LYMPHOMA PATIENTS?
por: Sayinalp, B., et al.
Publicado: (2022)

Identification of kit(M541L) somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response
por: Iurlo, Alessandra, et al.
Publicado: (2014)

S114: OUTCOME OF OLDER PATIENTS (>55 YRS) WITH NEWLY DIAGNOSED PH/BCR:ABL POSITIVE ALL PROSPECTIVELY TREATED ACCORDING TO PEDIATRIC-BASED, AGE-ADAPTED GMALL PROTOCOLS
por: Lang, Fabian, et al.
Publicado: (2023)

MiR-1180-5p regulates apoptosis of Wilms’ tumor by targeting p73
por: Jiang, Xiuyun, et al.
Publicado: (2018)

1180. Colonization with Multidrug-Resistant Organisms Is Associated with Subsequent Infection in the Ventricular Assist Device Population
por: Roberts, Scott C, et al.
Publicado: (2019)

Laser-Assisted Robotic Roller Forming of Ultrahigh-Strength Steel QP1180 with High Precision
por: Min, Junying, et al.
Publicado: (2023)

Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07
por: Bassan, Renato, et al.
Publicado: (2020)

Rate of Primary Refractory Disease in B and T-Cell Non-Hodgkin’s Lymphoma: Correlation with Long-Term Survival
por: Tarella, Corrado, et al.
Publicado: (2014)

The impact of the COVID-19 pandemic on individuals with mental illness: A two-wave survey of 1180 patients
por: Gil, Y., et al.
Publicado: (2021)

P355: FAVORABLE OUTCOME OF PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH IMATINIB, DOSE-REDUCED INDUCTION FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTATION –RESULTS FROM THE GMALL TRIAL 08/13
por: Pfeifer, Heike, et al.
Publicado: (2023)

Measurement and Analysis of the Horizontal Orbit in R2, Run 1180, 26 GeV/c, ring 2
por: Guignard, G
Publicado: (1981)

The status of the antiproton cooling system, Run 1162, 8.12.1980, Run 1180, 26.3.1981
por: Peschardt, E
Publicado: (1981)

Clinical significance of microRNA-1180-3p for colorectal cancer and effect of its alteration on cell function
por: Li, Chunlei, et al.
Publicado: (2021)

Burkitt leukaemia with B‐cell precursor immunophenotype
por: Xu, Ke, et al.
Publicado: (2022)

Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab
por: Rambaldi, Alessandro, et al.
Publicado: (2020)

Minimally Invasive Treatment of Sporadic Burkitt's Lymphoma Causing Ileocaecal Invagination
por: Panaccio, Paolo, et al.
Publicado: (2018)

Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma
por: Gonzalez-Farre, Blanca, et al.
Publicado: (2019)

Glutathione Surface Molecularly Imprinted Polymer from CLX1180 via Three Modes of Polymerization for Selective Adsorption of Glutathione
por: Zhang, Jun, et al.
Publicado: (2020)

Clinical characteristics analysis of 1180 patients with hepatocellular carcinoma secondary to hepatitis B, hepatitis C and alcoholic liver disease
por: Zhao, Heping, et al.
Publicado: (2019)

The plasma exosomal miR-1180-3p serves as a novel potential diagnostic marker for cutaneous melanoma
por: Guo, Yeye, et al.
Publicado: (2021)

P1180: ARE EXTRANODAL LIMITED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA MORE AGRESSIVE THAN NODAL FORMS?
por: Fernandes, C., et al.
Publicado: (2022)

Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives
por: Vannucchi, Alessandro M, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_cuf02r55lrporkdbrf9vvptq46